Shustik, Jesse. “Unique Toxicities of Novel Myeloma Therapies: Focus on Belantamab Mafodotin, Talquetamab, and Selinexor”. Canadian Hematology Today 4, no. 3 (December 8, 2025): 24–35. Accessed February 16, 2026. https://canadianhematologytoday.com/article/view/4-3-Shustik.